{"id":10893,"date":"2023-05-01T21:19:12","date_gmt":"2023-05-02T05:19:12","guid":{"rendered":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=10893"},"modified":"2023-05-01T21:19:40","modified_gmt":"2023-05-02T05:19:40","slug":"in-stock-fulphila-pegfilgrastim-jmdb-biosimilar-of-neulasta-6mg-0-6ml-syringe","status":"publish","type":"post","link":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=10893","title":{"rendered":"In Stock: Fulphila (Pegfilgrastim-jmdb, Biosimilar of Neulasta) 6mg\/0.6mL Syringe"},"content":{"rendered":"<p><strong><a href=\"https:\/\/store.apotheraspecialtypharmacy.com\/?product=fulphila-pegfilgrastim-jmdb-biosimilar-to-neulasta-6mg-0-6ml-syringe\">In Stock: Fulphila (Pegfilgrastim-jmdb, Biosimilar of Neulasta) 6mg\/0.6mL Syringe (Click Here)<\/a><\/strong><\/p>\n<div><strong>Prevention of Chemotherapy-Induced Neutropenia<\/strong><\/div>\n<div>\u2013 6 mg SC once per chemotherapy cycle, beginning at least 24 hours after completion of chemotherapy<\/div>\n<div>\u2013 Do not administer in the period between 14 days before and 24 hours after administration of cytotoxic chemotherapy.<\/div>\n<div><strong>Hematopoietic Radiation Injury Syndrome (Acute)<\/strong><\/div>\n<div>\u2013 6 mg SC once weekly for 2 doses<\/div>\n<div><strong>Manufacturer:<em>\u00a0<a href=\"https:\/\/www.mylan.com\/\">Mylan<\/a><\/em><\/strong><\/div>\n<div><img decoding=\"async\" src=\"https:\/\/i0.wp.com\/store.apotheraspecialtypharmacy.com\/wp-content\/uploads\/2022\/02\/Fulphilia.6mg.0.6mL-5.jpg?fit=423%2C212&amp;ssl=1\" \/><\/div>\n<div>\n<div>\n<div dir=\"ltr\" data-setdir=\"false\"><strong>Monitoring<\/strong><\/div>\n<div dir=\"ltr\" data-setdir=\"false\"><em><strong>Chemotherapy-Induced Neutropenia<\/strong><\/em><\/div>\n<div dir=\"ltr\" data-setdir=\"false\">\u2013 Complete blood count (with differential) and platelet count should be obtained prior to chemotherapy and as clinically necessary.<\/div>\n<div dir=\"ltr\" data-setdir=\"false\"><em><strong>Hematopoietic Radiation Injury Syndrome<\/strong><\/em><\/div>\n<div dir=\"ltr\" data-setdir=\"false\">\u2013 CBC at baseline (do not delay administration if CBC not readily available)<\/div>\n<div dir=\"ltr\" data-setdir=\"false\">\u2013 Estimate absorbed radiation dose<\/div>\n<div dir=\"ltr\" data-setdir=\"false\">\u2013 Evaluate fever, pulmonary infiltrates, and respiratory distress<\/div>\n<div dir=\"ltr\" data-setdir=\"false\">\u2013 Evaluate for left upper abdominal pain, shoulder tip pain, or splenomegaly<\/div>\n<div dir=\"ltr\" data-setdir=\"false\">\u2013 Monitor for signs\/symptoms of glomerulonephritis (azotemia, hematuria, proteinuria) and capillary leak syndrome (hypotension, hypoalbuminemia, edema and hemoconcentration)<\/div>\n<div dir=\"ltr\" data-setdir=\"false\">\u2013 Monitor for sickle cell crisis (in patients with sickle cell anemia)<\/div>\n<div dir=\"ltr\" data-setdir=\"false\"><\/div>\n<\/div>\n<div><strong>SC Administration<\/strong><\/div>\n<div>\u2013 Administer subcutaneously<\/div>\n<div>\u2013 Do not use 6 mg fixed dose in infants, children, or adolescents &lt;45 kg<\/div>\n<div>\u00a0Pegfilgrastim is available in prefilled syringes for manual subcutaneous administration or as a kit for use with the On-body injector<\/div>\n<div>\u2013 Direct administration of doses &lt;6 mg using the prefilled syringe is not recommended by the manufacturer (it does not have graduation marks necessary for accurate measurement of doses other than 6 mg)<\/div>\n<div>\u2013 Use caution to avoid dosing errors<\/div>\n<div><strong>\u00a0<\/strong><\/div>\n<div><strong>Storage<\/strong><\/div>\n<div>\u2013 Store under refrigeration at 2\u00b0C to 8\u00b0C (36\u00b0F to 46\u00b0F)<\/div>\n<div>\u2013 Do not freeze.<\/div>\n<div>\u2013 If syringe for manual injection is inadvertently frozen, allow to thaw in refrigerator; discard if frozen more than one time<\/div>\n<div>\u2013 Protect from light.<\/div>\n<div>\u2013 Do not shake.<\/div>\n<div><em><strong>Pre-filled Syringe<\/strong><\/em><\/div>\n<div>\u2013 Allow prefilled syringe to reach room temperature for at least 30 minutes prior to injection<\/div>\n<div>\u2013 Discard if kept at room temperature for longer than 48 hours<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>In Stock: Fulphila (Pegfilgrastim-jmdb, Biosimilar of Neulasta) 6mg\/0.6mL Syringe (Click Here) Prevention of Chemotherapy-Induced Neutropenia \u2013 6 mg SC once per chemotherapy cycle, beginning at least 24 hours after completion&hellip;<\/p>\n","protected":false},"author":6,"featured_media":10894,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[16],"tags":[275,904,1795,905,266,1550,517,1796,1815,1816,1810,1813,1812,1811,1814,1797,906,1532,1112,907,909,910,1798,818,1804,1807,1801,1806,1803,1802,1805,911,819,913,915,916],"class_list":["post-10893","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","tag-cancer","tag-cedars-sinai","tag-chemotherapy-induced-neutropenia","tag-clinical-decision-support-application","tag-drug-information","tag-drugs-com","tag-drugstore-com","tag-fulphila","tag-fulphila-dana-point","tag-fulphila-huntington-beach","tag-fulphila-irvine","tag-fulphila-laguna-beach","tag-fulphila-newport-beach","tag-fulphila-newport-coast","tag-fulphila-san-clemente","tag-hematopoietic-radiation-injury-syndrome-acute","tag-hoag-concierge-medicine","tag-hoag-concierge-medicine-newport-beach","tag-hoag-health","tag-hoag-hospital","tag-medicine-information","tag-medicine-information-application","tag-mylan","tag-neulasta","tag-neulasta-dana-point","tag-neulasta-huntington-beach","tag-neulasta-irvine","tag-neulasta-laguna-beach","tag-neulasta-newport-beach","tag-neulasta-newport-coast","tag-neulasta-san-clemente","tag-online-pharmacy","tag-pegfilgrastim","tag-point-of-care-medical-application","tag-telehealth","tag-telemedicine"],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/store.apotheraspecialtypharmacy.com\/wp-content\/uploads\/2023\/05\/Fulphilia.6mg.0.6mL-3.jpg?fit=521%2C292&ssl=1","jetpack-related-posts":[{"id":9979,"url":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=9979","url_meta":{"origin":10893,"position":0},"title":"In Stock: Pegfilgrastim-jmdb (Fulphila, Biosimilar to Neulasta) 6mg\/0.6mL Syringe","date":"March 29, 2023","format":false,"excerpt":"In Stock: Fulphila Biosimilar to Neulasta (Pegfilgrastim-jmdb) 6mg\/0.6mL Syringe (Click Here) Prevention of Chemotherapy-Induced Neutropenia \u2013 6 mg SC once per chemotherapy cycle, beginning at least 24 hours after completion of chemotherapy \u2013 Do not administer in the period between 14 days before and 24 hours after administration of cytotoxic\u2026","rel":"","context":"In &quot;Blog&quot;","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":10091,"url":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=10091","url_meta":{"origin":10893,"position":1},"title":"In Stock: Neulasta Biosimilar (Fulphila, Pegfilgrastim-jmdb) 6mg\/0.6mL Syringe","date":"April 2, 2023","format":false,"excerpt":"In Stock: Neulasta Biosimilar (Fulphila, Pegfilgrastim-jmdb) 6mg\/0.6mL (Click Here) Prevention of Chemotherapy-Induced Neutropenia \u2013 6 mg SC once per chemotherapy cycle, beginning at least 24 hours after completion of chemotherapy \u2013 Do not administer in the period between 14 days before and 24 hours after administration of cytotoxic chemotherapy. \u00a0\u2026","rel":"","context":"In &quot;Blog&quot;","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":10056,"url":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=10056","url_meta":{"origin":10893,"position":2},"title":"In Stock: Fylnetra (Pegfilgrastim-pbbk, Biosimilar to Neulasta) 6mg\/0.6mL Syringe","date":"April 1, 2023","format":false,"excerpt":"In Stock: Fylnetra 6mg\/0.6mL Neulasta Biosimilar (Click Here) Prevention of Chemotherapy-Induced Neutropenia \u2013 6 mg SC once per chemotherapy cycle, beginning at least 24 hours after completion of chemotherapy \u2013 Do not administer in the period between 14 days before and 24 hours after administration of cytotoxic chemotherapy. Find a\u2026","rel":"","context":"In &quot;Blog&quot;","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":11152,"url":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=11152","url_meta":{"origin":10893,"position":3},"title":"In Stock:\u00a0Pegfilgrastim\u00a0(Fylnetra, Fulphila, Neulasta, Stimufend, Udenyca, Ziextenzo) | Cancer Supportive Care | ApoThera | Irvine, Orange County, California","date":"May 11, 2023","format":false,"excerpt":"In Stock: Pegfilgrastim - Biosimilars of Neulasta (Click Here) \u2013 Rx Required \u2013 Free Overnight Shipping (CA) \u2013 No Shipping to Outside of California \u2013 Accept FSA and HSA Cards \u2013 Accept Credit Cards Prevention of Chemotherapy-Induced Neutropenia \u2013 6 mg SC once per chemotherapy cycle, beginning at least 24\u2026","rel":"","context":"In &quot;Blog&quot;","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":10896,"url":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=10896","url_meta":{"origin":10893,"position":4},"title":"In Stock: Fylnetra (Pegfilgrastim-pbbk, Biosimilar to Neulasta) 6mg\/0.6mL Syringe","date":"May 1, 2023","format":false,"excerpt":"In Stock: Fylnetra (Pegfilgrastim-pbbk, Biosimilar of Neulasta) 6mg\/0.6mL Syringe (Click Here) Prevention of Chemotherapy-Induced Neutropenia \u2013 6 mg SC once per chemotherapy cycle, beginning at least 24 hours after completion of chemotherapy \u2013 Do not administer in the period between 14 days before and 24 hours after administration of cytotoxic\u2026","rel":"","context":"In &quot;Blog&quot;","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":8013,"url":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=8013","url_meta":{"origin":10893,"position":5},"title":"FDA Approves Fylnetra (pegfilgrastim-pbbk), Biosimilar to Neulasta (pegfilgrastim), for Treating Neutropenia","date":"June 12, 2022","format":false,"excerpt":"Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (\u201cAmneal\u201d or the \u201cCompany\u201d) today announced that the U.S. Food and Drug Administration (\u201cFDA\u201d) has approved the Company\u2019s Biologics License Application (\u201cBLA\u201d) for pegfilgrastim-pbbk, a biosimilar referencing Neulasta\u00ae. The product will be marketed under the proprietary name FYLNETRA\u2122. FYLNETRA was developed in collaboration with Kashiv\u2026","rel":"","context":"In &quot;Blog&quot;","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=\/wp\/v2\/posts\/10893","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=10893"}],"version-history":[{"count":1,"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=\/wp\/v2\/posts\/10893\/revisions"}],"predecessor-version":[{"id":10895,"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=\/wp\/v2\/posts\/10893\/revisions\/10895"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=\/wp\/v2\/media\/10894"}],"wp:attachment":[{"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=10893"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=10893"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=10893"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}